Insitro Funding & Investors
Insitro is an operator of a data-driven drug discovery and development company that utilizes machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company uses state-of-the-art technologies from bioengineering enabling it to generate high-throughput, functional genomic data sets and aligning them with patient data via novel machine learning methods, thereby building predictive models that can accelerate target selection and the design and development of effective therapeutics. In 2018, Daphne Koller established Insitro in South San Francisco, California..
insitro.comTotal Amount Raised: $643,000,000
Insitro Funding Rounds
Series C
$400,000,000
Series C Investors
CPP InvestmentsArch Venture PartnersAndreessen HorowitzTwo Sigma VenturesThird Rock VenturesT. Rowe PriceTemasekCasdin CapitalForesite CapitalGVHOF CapitalBlackRockAlexandria Venture InvestmentsSoftBank Vision FundSeries B
$143,000,000
Series B Investors
Andreessen HorowitzWuXi AppTecTwo Sigma VenturesArch Venture PartnersThird Rock VenturesHOF CapitalForesite CapitalT. Rowe PriceCPP InvestmentsBlackRockGVAlexandria Venture InvestmentsCasdin CapitalVictor WangSeries A
$100,000,000
Series A Investors
Foresite CapitalGVThird Rock VenturesAndreessen HorowitzArch Venture PartnersAlexandria Venture InvestmentsTwo Sigma VenturesBezos ExpeditionsVerilyMubadala
Funding info provided by Diffbot.